Ep 5: Dr. Lanzkron Discusses Hydroxyurea and Quality Care

This month, we recognize September as Sickle Cell Disease Awareness Month. Dr. Sophie Lanzkron is Director of the Sickle Cell Center for Adults at The Johns Hopkins Hospital. The sickle cell community has benefited greatly from her research, leadership, and expertise. Dr. Lanzkron research focuses on sickle cell disease, hydroxyurea, patient-centered health care, and health services research. On this episode, she discusses her journey and love for hematology, overview of hydroxyurea, and quality care for sickle cell disease patients.